Successful treatment of pneumocystis carinii in an immunologically deficient acute lymphatic leukemia patient.
D000293:Adolescent; D000361:Agammaglobulinemia / Q000139:chemically induced / Q000276:immunology*; D000578:Amidines / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M; D007153:Immunologic Deficiency Syndromes; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy* / Q000276:immunology
D000578:Amidines; D000779:Anesthetics, Local; D000970:Antineoplastic Agents; D000981:Antiprotozoal Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008727:Methotrexate